The European Union’s medicines agency has approved Moderna’s coronavirus vaccine candidate, giving the bloc a second vaccine to use in its battle against the pandemic.
The approval recommendation by the European Medicines Agency’s human medicines committee comes amid strong criticism of the slow pace at which the vaccine rollout programme is being carried out across the region of some 450 million people.
The EMA approved a Covid-19 vaccine developed by Pfizer and BioNTech before Christmas, and began rolling it out to citizens of the 27-nation bloc shortly after. Both vaccines require giving people two jabs.
Emer Cooke, executive director of EMA, said: “This vaccine provides us with another tool to overcome the current emergency.
“It is a testament to the efforts and commitment of all involved that we have this second positive vaccine recommendation just short of a year since the pandemic was declared by WHO.”